{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:30:09Z","timestamp":1793313009021,"version":"4.5.0"},"reference-count":210,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100014269","name":"Philippe Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007492","name":"Fondation Bettencourt Schueller","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH116038"],"award-info":[{"award-number":["R01MH116038"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["U01MH121766"],"award-info":[{"award-number":["U01MH121766"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience & Biobehavioral Reviews"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.neubiorev.2025.106239","type":"journal-article","created":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T19:38:21Z","timestamp":1748720301000},"page":"106239","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Neurocognitive effects of psilocybin: A systematic and comprehensive review of neuroimaging studies in humans"],"prefix":"10.1016","volume":"175","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5098-7921","authenticated-orcid":false,"given":"Lucie","family":"Berkovitch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baptiste","family":"Fauvel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin H.","family":"Preller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rapha\u00ebl","family":"Gaillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neubiorev.2025.106239_bib1","article-title":"Single-dose synthetic psilocybin with psychotherapy for treatment-resistant bipolar type II major depressive episodes: a nonrandomized controlled trial","author":"Aaronson","year":"2023","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106239_bib2","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1007\/s00213-022-06123-7","article-title":"Great Expectations: recommendations for improving the methodological rigor of psychedelic clinical trials","volume":"239","author":"Aday","year":"2022","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neubiorev.2025.106239_bib3","article-title":"Amygdala response to emotional faces following acute administration of psilocybin in healthy individuals","author":"Armand","year":"2023","journal-title":"Neurosci. Appl."},{"key":"10.1016\/j.neubiorev.2025.106239_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2019.116462","article-title":"Decreased directed functional connectivity in the psychedelic state","volume":"209","author":"Barnett","year":"2020","journal-title":"Neuroimage"},{"key":"10.1016\/j.neubiorev.2025.106239_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-59282-y","article-title":"Emotions and brain function are altered up to one month after a single high dose of psilocybin","volume":"10","author":"Barrett","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neubiorev.2025.106239_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2020.116980","article-title":"Psilocybin acutely alters the functional connectivity of the claustrum with brain networks that support perception, memory, and attention","volume":"218","author":"Barrett","year":"2020","journal-title":"NeuroImage"},{"key":"10.1016\/j.neubiorev.2025.106239_bib7","doi-asserted-by":"crossref","DOI":"10.1093\/nc\/niy008","article-title":"Dimensions of consciousness and the psychedelic state","volume":"2018","author":"Bayne","year":"2018","journal-title":"Neurosci. Conscious."},{"key":"10.1016\/j.neubiorev.2025.106239_bib8","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.tics.2017.08.006","article-title":"Disruption of conscious access in schizophrenia","volume":"21","author":"Berkovitch","year":"2017","journal-title":"Trends Cogn. Sci. (Regul. Ed.)"},{"key":"10.1016\/j.neubiorev.2025.106239_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.encep.2020.12.002","article-title":"Efficacit\u00e9 des psych\u00e9d\u00e9liques en psychiatrie, une revue syst\u00e9matique","author":"Berkovitch","year":"2021","journal-title":"L\u2019Enc\u00e9phale"},{"key":"10.1016\/j.neubiorev.2025.106239_bib10","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1093\/cercor\/bht178","article-title":"Spatiotemporal brain dynamics of emotional face processing modulations induced by the serotonin 1A\/2A receptor agonist psilocybin","volume":"24","author":"Bernasconi","year":"2014","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neubiorev.2025.106239_bib11","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/0269881114565144","article-title":"Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study","volume":"29","author":"Bogenschutz","year":"2015","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neubiorev.2025.106239_bib12","doi-asserted-by":"crossref","DOI":"10.1001\/jamapsychiatry.2022.2096","article-title":"Percentage of heavy drinking days following psilocybin-assisted psychotherapy vs placebo in the treatment of adult patients with alcohol use disorder: a randomized clinical trial","author":"Bogenschutz","year":"2022","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106239_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2023.105410","article-title":"Storm on predictive brain: a neurocomputational account of ketamine antidepressant effect","volume":"154","author":"Bottemanne","year":"2023","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neubiorev.2025.106239_bib14","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00213-017-4807-2","article-title":"Psilocybin disrupts sensory and higher order cognitive processing but not pre-attentive cognitive processing\u2014study on P300 and mismatch negativity in healthy volunteers","volume":"235","author":"Bravermanov\u00e1","year":"2018","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neubiorev.2025.106239_bib15","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1126\/science.1138071","article-title":"Top-down versus bottom-up control of attention in the prefrontal and posterior parietal cortices","volume":"315","author":"Buschman","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.neubiorev.2025.106239_bib16","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1007\/s00213-022-06221-6","article-title":"Expectancy in placebo-controlled trials of psychedelics: if so, so what?","volume":"239","author":"Butler","year":"2022","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neubiorev.2025.106239_bib17","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1038\/srep02027","article-title":"A quantitative meta-analysis of functional imaging studies of social rejection","volume":"3","author":"Cacioppo","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neubiorev.2025.106239_bib18","first-page":"1","article-title":"Towards an understanding of psychedelic-induced neuroplasticity","author":"Calder","year":"2022","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.neubiorev.2025.106239_bib19","doi-asserted-by":"crossref","first-page":"7472","DOI":"10.1523\/JNEUROSCI.1384-23.2023","article-title":"Beyond the 5-HT2A receptor: classic and nonclassic targets in psychedelic drug action","volume":"43","author":"Cameron","year":"2023","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2025.106239_bib20","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.neuropharm.2018.03.010","article-title":"The entropic brain \u2013 revisited","volume":"142","author":"Carhart-Harris","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neubiorev.2025.106239_bib21","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00213-017-4771-x","article-title":"Psilocybin with psychological support for treatment-resistant depression: six-month follow-up","volume":"235","author":"Carhart-Harris","year":"2018","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neubiorev.2025.106239_bib22","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S2215-0366(16)30065-7","article-title":"Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study","volume":"3","author":"Carhart-Harris","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106239_bib23","doi-asserted-by":"crossref","DOI":"10.1177\/0269881113494107","article-title":"Psychiatry\u2019s next top model: cause for a re-think on drug models of psychosis and other psychiatric disorders","author":"Carhart-Harris","year":"2013","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neubiorev.2025.106239_bib24","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1073\/pnas.1119598109","article-title":"Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin","volume":"109","author":"Carhart-Harris","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neubiorev.2025.106239_bib25","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1124\/pr.118.017160","article-title":"REBUS and the anarchic brain: towards a unified model of the brain action of psychedelics","volume":"71","author":"Carhart-Harris","year":"2019","journal-title":"Pharm. Rev."},{"key":"10.1016\/j.neubiorev.2025.106239_bib26","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa2032994","article-title":"Trial of psilocybin versus escitalopram for depression","volume":"384","author":"Carhart-Harris","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neubiorev.2025.106239_bib27","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1093\/schbul\/sbs117","article-title":"Functional connectivity measures after psilocybin inform a novel hypothesis of early psychosis","volume":"39","author":"Carhart-Harris","year":"2013","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neubiorev.2025.106239_bib28","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3389\/fnhum.2014.00020","article-title":"The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs","volume":"8","author":"Carhart-Harris","year":"2014","journal-title":"Front. Hum. Neurosci."},{"key":"10.1016\/j.neubiorev.2025.106239_bib29","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1192\/bjp.bp.111.103309","article-title":"Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin","volume":"200","author":"Carhart-Harris","year":"2012","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106239_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-13282-7","article-title":"Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms","volume":"7","author":"Carhart-Harris","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neubiorev.2025.106239_bib31","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1177\/0269881118754710","article-title":"Psychedelics and the essential importance of context","volume":"32","author":"Carhart-Harris","year":"2018","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neubiorev.2025.106239_bib32","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/sj.npp.1300621","article-title":"Modulating the rate and rhythmicity of perceptual rivalry alternations with the mixed 5-HT2A and 5-HT1A agonist psilocybin","volume":"30","author":"Carter","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2025.106239_bib33","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41398-022-02039-0","article-title":"Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study","volume":"12","author":"Cavanna","year":"2022","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106239_bib34","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jad.2024.02.089","article-title":"Predicting the outcome of psilocybin treatment for depression from baseline fMRI functional connectivity","volume":"353","author":"Copa","year":"2024","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neubiorev.2025.106239_bib35","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1177\/0269881107077716","article-title":"From prediction error to psychosis: ketamine as a pharmacological model of delusions","volume":"21","author":"Corlett","year":"2007","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neubiorev.2025.106239_bib36","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1523\/JNEUROSCI.4675-12.2013","article-title":"Temporal expectation enhances contrast sensitivity by phase entrainment of low-frequency oscillations in visual cortex","volume":"33","author":"Cravo","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2025.106239_bib37","article-title":"Effects of psilocybin-assisted therapy on major depressive disorder: a randomized clinical trial","author":"Davis","year":"2020","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106239_bib38","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/s41591-022-01744-z","article-title":"Increased global integration in the brain after psilocybin therapy for depression","volume":"28","author":"Daws","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.neubiorev.2025.106239_bib39","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/s44220-024-00298-y","article-title":"Different hierarchical reconfigurations in the brain by psilocybin and escitalopram for depression","volume":"2","author":"Deco","year":"2024","journal-title":"Nat. Ment. Health"},{"key":"10.1016\/j.neubiorev.2025.106239_bib40","doi-asserted-by":"crossref","first-page":"14529","DOI":"10.1073\/pnas.95.24.14529","article-title":"A neuronal model of a global workspace in effortful cognitive tasks","volume":"95","author":"Dehaene","year":"1998","journal-title":"PNAS"},{"key":"10.1016\/j.neubiorev.2025.106239_bib41","article-title":"Models of psychedelic drug action: modulation of cortical-subcortical circuits","volume":"awab406","author":"Doss","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.neubiorev.2025.106239_bib42","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/s41398-021-01706-y","article-title":"Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder","volume":"11","author":"Doss","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106239_bib43","article-title":"Corolaires en neuro-imagerie des effets des psych\u00e9d\u00e9liques classiques: une revue syst\u00e9matique de la litt\u00e9rature","author":"Dost","year":"2024","journal-title":"L\u2019Enc\u00e9phale"},{"key":"10.1016\/j.neubiorev.2025.106239_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.602590","article-title":"The effects of daytime psilocybin administration on sleep: implications for antidepressant action","volume":"11","author":"Dudysov\u00e1","year":"2020","journal-title":"Front. Pharm."},{"key":"10.1016\/j.neubiorev.2025.106239_bib45","article-title":"Psilocybin induces aberrant prediction error processing of tactile mismatch responses\u2014a simultaneous EEG\u2013FMRI study","volume":"bhab202","author":"Duerler","year":"2021","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neubiorev.2025.106239_bib46","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1126\/science.1089134","article-title":"Does rejection hurt? An FMRI study of social exclusion","volume":"302","author":"Eisenberger","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.neubiorev.2025.106239_bib47","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s44220-023-00172-3","article-title":"Exploring mechanisms of psychedelic action using neuroimaging","volume":"2","author":"Erritzoe","year":"2024","journal-title":"Nat. Ment. Health"},{"key":"10.1016\/j.neubiorev.2025.106239_bib48","doi-asserted-by":"crossref","DOI":"10.1177\/20451253231172254","article-title":"The psychedelic afterglow phenomenon: a systematic review of subacute effects of classic serotonergic psychedelics","volume":"13","author":"Evens","year":"2023","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.neubiorev.2025.106239_bib49","series-title":"The Psychedelic Explorer\u2019s Guide: Safe, Therapeutic, and Sacred Journeys","author":"Fadiman","year":"2011"},{"key":"10.1016\/j.neubiorev.2025.106239_bib50","first-page":"132","article-title":"Le fa\u00e7onnement neuropharmacologique de la culture. Anthropologie compar\u00e9e des rituels \u00e0 hallucinog\u00e8nes s\u00e9rotoninergiques et anticholinergiques","author":"Fortier","year":"2019","journal-title":"Cah. d\u2019anthropol. Soc."},{"key":"10.1016\/j.neubiorev.2025.106239_bib51","doi-asserted-by":"crossref","first-page":"9673","DOI":"10.1073\/pnas.0504136102","article-title":"The human brain is intrinsically organized into dynamic, anticorrelated functional networks","volume":"102","author":"Fox","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neubiorev.2025.106239_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroimage.2022.119434","article-title":"Psilocybin induces spatially constrained alterations in thalamic functional organizaton and connectivity","volume":"260","author":"Gaddis","year":"2022","journal-title":"NeuroImage"},{"key":"10.1016\/j.neubiorev.2025.106239_bib53","doi-asserted-by":"crossref","first-page":"7524","DOI":"10.1073\/pnas.0600584103","article-title":"Nonconscious semantic processing of emotional words modulates conscious access","volume":"103","author":"Gaillard","year":"2006","journal-title":"PNAS"},{"key":"10.1016\/j.neubiorev.2025.106239_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2022.119220","article-title":"Serotonergic psychedelic drugs LSD and psilocybin reduce the hierarchical differentiation of unimodal and transmodal cortex","volume":"256","author":"Girn","year":"2022","journal-title":"NeuroImage"},{"key":"10.1016\/j.neubiorev.2025.106239_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2020.112749","article-title":"The experimental effects of psilocybin on symptoms of anxiety and depression: a meta-analysis","volume":"284","author":"Goldberg","year":"2020","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.neubiorev.2025.106239_bib56","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.tins.2008.12.005","article-title":"Psychedelics and schizophrenia","volume":"32","author":"Gonz\u00e1lez-Maeso","year":"2009","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neubiorev.2025.106239_bib57","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJMoa2206443","article-title":"Single-dose psilocybin for a treatment-resistant episode of major depression","volume":"387","author":"Goodwin","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neubiorev.2025.106239_bib58","doi-asserted-by":"crossref","DOI":"10.1038\/s41386-023-01648-7","article-title":"Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication","author":"Goodwin","year":"2023","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2025.106239_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2021.645246","article-title":"Psychedelic harm reduction and integration: a transtheoretical model for clinical practice","volume":"12","author":"Gorman","year":"2021","journal-title":"Front. Psychol."},{"key":"10.1016\/j.neubiorev.2025.106239_bib60","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0893-133X(98)00089-X","article-title":"Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers. A double-blind, placebo-controlled PET study with [18F]FDG","volume":"20","author":"Gouzoulis-Mayfrank","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2025.106239_bib61","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1177\/0269881116675513","article-title":"Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial","volume":"30","author":"Griffiths","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neubiorev.2025.106239_bib62","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s00213-011-2358-5","article-title":"Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects","volume":"218","author":"Griffiths","year":"2011","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neubiorev.2025.106239_bib63","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1177\/0269881108094300","article-title":"Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later","volume":"22","author":"Griffiths","year":"2008","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neubiorev.2025.106239_bib64","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s00213-006-0457-5","article-title":"Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance","volume":"187","author":"Griffiths","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neubiorev.2025.106239_bib65","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.euroneuro.2018.03.016","article-title":"Psilocybin modulates functional connectivity of the amygdala during emotional face discrimination","volume":"28","author":"Grimm","year":"2018","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neubiorev.2025.106239_bib66","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archgenpsychiatry.2010.116","article-title":"Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer","volume":"68","author":"Grob","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106239_bib67","article-title":"Treatment with psychedelics is psychotherapy: beyond reductionism","author":"Gr\u00fcnder","year":"2023","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106239_bib68","doi-asserted-by":"crossref","DOI":"10.1177\/23982128211007772","article-title":"A continuum hypothesis of psychotomimetic rapid antidepressants","volume":"5","author":"Haarsma","year":"2021","journal-title":"Brain Neurosci. Adv."},{"key":"10.1016\/j.neubiorev.2025.106239_bib69","first-page":"1","article-title":"Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprises","author":"Harding","year":"2025","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106239_bib70","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S2215-0366(17)30015-9","article-title":"How do antidepressants work? New perspectives for refining future treatment approaches","volume":"4","author":"Harmer","year":"2017","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106239_bib71","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jcbs.2019.11.005","article-title":"The centrality of sense of self in psychological flexibility processes: What the neurobiological and psychological correlates of psychedelics suggest","volume":"15","author":"Hayes","year":"2020","journal-title":"J. Context. Behav. Sci."},{"key":"10.1016\/j.neubiorev.2025.106239_bib72","doi-asserted-by":"crossref","first-page":"9457","DOI":"10.1073\/pnas.1705965114","article-title":"Prefrontal cortex modulates posterior alpha oscillations during top-down guided visual perception","volume":"114","author":"Helfrich","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neubiorev.2025.106239_bib73","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2022489118","article-title":"Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice","volume":"118","author":"Hesselgrave","year":"2021","journal-title":"PNAS"},{"key":"10.1016\/j.neubiorev.2025.106239_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2024.01.197","article-title":"Longitudinal associations between psychedelic use and psychotic symptoms in the United States and United Kingdom","author":"Honk","year":"2024","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neubiorev.2025.106239_bib75","first-page":"1","article-title":"Mechanisms and molecular targets surrounding the potential therapeutic effects of psychedelics","author":"Jaster","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106239_bib76","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.66968","article-title":"Mapping brain-behavior space relationships along the psychosis spectrum","volume":"10","author":"Ji","year":"2021","journal-title":"eLife"},{"key":"10.1016\/j.neubiorev.2025.106239_bib77","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1177\/0269881114548296","article-title":"Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction","volume":"28","author":"Johnson","year":"2014","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neubiorev.2025.106239_bib78","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-63687-4","article-title":"Endorsement of metaphysical idealism mediates a link between past use of psychedelics and wellbeing","volume":"14","author":"Jylkk\u00e4","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neubiorev.2025.106239_bib79","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.neuroimage.2015.08.012","article-title":"Single-dose serotonergic stimulation shows widespread effects on functional brain connectivity","volume":"122","author":"Klaassens","year":"2015","journal-title":"NeuroImage"},{"key":"10.1016\/j.neubiorev.2025.106239_bib80","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.biopsych.2010.10.002","article-title":"The 5-HT2A\/1A agonist psilocybin disrupts modal object completion associated with visual hallucinations","volume":"69","author":"Kometer","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106239_bib81","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1007\/s00213-015-4026-7","article-title":"Psilocybin-induced spiritual experiences and insightfulness are associated with synchronization of neuronal oscillations","volume":"232","author":"Kometer","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neubiorev.2025.106239_bib82","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.biopsych.2012.04.005","article-title":"Psilocybin biases facial recognition, goal-directed behavior, and mood state towards positive relative to negative emotions through different serotonergic subreceptors","volume":"72","author":"Kometer","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106239_bib83","doi-asserted-by":"crossref","first-page":"10544","DOI":"10.1523\/JNEUROSCI.3007-12.2013","article-title":"Activation of serotonin 2A receptors underlies the psilocybin-induced effects on \u03b1 oscillations, N170 visual-evoked potentials, and visual hallucinations","volume":"33","author":"Kometer","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2025.106239_bib84","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/7854_2016_461","article-title":"Serotonergic hallucinogen-induced visual perceptual alterations","volume":"36","author":"Kometer","year":"2018","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.neubiorev.2025.106239_bib85","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.tics.2010.04.006","article-title":"How rich is consciousness? The partial awareness hypothesis","volume":"14","author":"Kouider","year":"2010","journal-title":"Trends Cogn. Sci."},{"key":"10.1016\/j.neubiorev.2025.106239_bib86","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.biopsych.2014.04.010","article-title":"Psilocybin-induced decrease in amygdala reactivity correlates with enhanced positive mood in healthy volunteers","volume":"78","author":"Kraehenmann","year":"2015","journal-title":"Biol. Psychiatry Serotonin Mood Anxiety"},{"key":"10.1016\/j.neubiorev.2025.106239_bib87","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.nicl.2015.08.009","article-title":"The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity","volume":"11","author":"Kraehenmann","year":"2016","journal-title":"Neuroimage Clin."},{"key":"10.1016\/j.neubiorev.2025.106239_bib88","doi-asserted-by":"crossref","first-page":"9566","DOI":"10.1073\/pnas.1921475117","article-title":"Dynamic coupling of whole-brain neuronal and neurotransmitter systems","volume":"117","author":"Kringelbach","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neubiorev.2025.106239_bib89","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.biopsych.2007.08.017","article-title":"Neuroplasticity as a target for the pharmacotherapy of psychiatric disorders: new opportunities for synergy with psychotherapy","volume":"62","author":"Krystal","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106239_bib90","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","article-title":"Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans: psychotomimetic, perceptual, cognitive, and neuroendocrine responses","volume":"51","author":"Krystal","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106239_bib91","first-page":"1","article-title":"The neural basis of psychedelic action","author":"Kwan","year":"2022","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neubiorev.2025.106239_bib92","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1021\/acschemneuro.8b00615","article-title":"DARK classics in chemical neuroscience: atropine, scopolamine, and other anticholinergic deliriant hallucinogens","volume":"10","author":"Lakstygal","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neubiorev.2025.106239_bib93","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.tins.2012.11.006","article-title":"A cellular mechanism for cortical associations: an organizing principle for the cerebral cortex","volume":"36","author":"Larkum","year":"2013","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neubiorev.2025.106239_bib94","doi-asserted-by":"crossref","DOI":"10.1177\/0271678X251323364","article-title":"Acute psilocybin and ketanserin effects on cerebral blood flow: 5-HT2AR neuromodulation in healthy humans","author":"Larsen","year":"2025","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neubiorev.2025.106239_bib95","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1002\/hbm.22833","article-title":"Finding the self by losing the self: neural correlates of ego-dissolution under psilocybin","volume":"36","author":"Lebedev","year":"2015","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.neubiorev.2025.106239_bib96","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1093\/schbul\/sbaa117","article-title":"Hallucinations under psychedelics and in the schizophrenia spectrum: an interdisciplinary and multiscale comparison","volume":"46","author":"Leptourgos","year":"2020","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neubiorev.2025.106239_bib97","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines8020034","article-title":"Rostral anterior cingulate thickness predicts the emotional psilocybin experience","volume":"8","author":"Lewis","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.neubiorev.2025.106239_bib98","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neuroimage.2017.07.020","article-title":"Two dose investigation of the 5-HT-agonist psilocybin on relative and global cerebral blood flow","volume":"159","author":"Lewis","year":"2017","journal-title":"Neuroimage"},{"key":"10.1016\/j.neubiorev.2025.106239_bib99","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Med."},{"key":"10.1016\/j.neubiorev.2025.106239_bib100","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/schbul\/sbq074","article-title":"Schizophrenic patients and their unaffected siblings share increased resting-state connectivity in the task-negative network but not its anticorrelated task-positive network","volume":"38","author":"Liu","year":"2012","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neubiorev.2025.106239_bib101","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.neuroimage.2019.05.060","article-title":"Dynamical exploration of the repertoire of brain networks at rest is modulated by psilocybin","volume":"199","author":"Lord","year":"2019","journal-title":"NeuroImage"},{"key":"10.1016\/j.neubiorev.2025.106239_bib102","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.748359","article-title":"Serotonergic psychedelics in neural plasticity","volume":"14","author":"Lukasiewicz","year":"2021","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neubiorev.2025.106239_bib103","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adf8332","article-title":"In vivo mapping of pharmacologically induced functional reorganization onto the human brain\u2019s neurotransmitter landscape","volume":"9","author":"Luppi","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.neubiorev.2025.106239_bib104","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1016\/j.celrep.2018.05.022","article-title":"Psychedelics promote structural and functional neural plasticity","volume":"23","author":"Ly","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.neubiorev.2025.106239_bib105","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1038\/s41386-019-0324-9","article-title":"Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels","volume":"44","author":"Madsen","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2025.106239_bib106","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.euroneuro.2020.02.001","article-title":"A single psilocybin dose is associated with long-term increased mindfulness, preceded by a proportional change in neocortical 5-HT2A receptor binding","volume":"33","author":"Madsen","year":"2020","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neubiorev.2025.106239_bib107","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/head.14656","article-title":"CCH attack frequency reduction after psilocybin correlates with hypothalamic functional connectivity","volume":"64","author":"Madsen","year":"2024","journal-title":"Headache: J. Head Face Pain"},{"key":"10.1016\/j.neubiorev.2025.106239_bib108","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.euroneuro.2021.06.001","article-title":"Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experience","volume":"50","author":"Madsen","year":"2021","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neubiorev.2025.106239_bib109","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1038\/s41386-020-0718-8","article-title":"Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin","volume":"45","author":"Mason","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2025.106239_bib110","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41398-021-01335-5","article-title":"Spontaneous and deliberate creative cognition during and after psilocybin exposure","volume":"11","author":"Mason","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106239_bib111","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1093\/cercor\/bhv146","article-title":"Expecting to see a letter: alpha oscillations as carriers of top-down sensory predictions","volume":"26","author":"Mayer","year":"2016","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neubiorev.2025.106239_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104689","article-title":"Psychedelic resting-state neuroimaging: a review and perspective on balancing replication and novel analyses","volume":"138","author":"McCulloch","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neubiorev.2025.106239_bib113","article-title":"Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals","author":"McCulloch","year":"2021","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neubiorev.2025.106239_bib114","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1177\/0269881119895520","article-title":"Therapeutic mechanisms of psilocybin: changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression","volume":"34","author":"Mertens","year":"2020","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neubiorev.2025.106239_bib115","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.3389\/fpsyg.2018.01475","article-title":"Psychedelics, meditation, and self-consciousness","volume":"9","author":"Milli\u00e8re","year":"2018","journal-title":"Front. Psychol."},{"key":"10.1016\/j.neubiorev.2025.106239_bib116","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/s41593-023-01316-5","article-title":"Psychedelics promote plasticity by directly binding to BDNF receptor TrkB","volume":"26","author":"Moliner","year":"2023","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neubiorev.2025.106239_bib117","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.4088\/JCP.v67n1110","article-title":"Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder","volume":"67","author":"Moreno","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106239_bib118","first-page":"681","article-title":"Dynamic functional hyperconnectivity after psilocybin intake is primarily associated with oceanic boundlessness","volume":"9","author":"Mortaheb","year":"2024","journal-title":"Biol. Psychiatry: Cogn. Neurosci. Neuroimaging"},{"key":"10.1016\/j.neubiorev.2025.106239_bib119","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.biopsych.2022.10.021","article-title":"Towards mapping neurobehavioral heterogeneity of psychedelic neurobiology in humans","volume":"93","author":"Moujaes","year":"2023","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106239_bib120","article-title":"Comparing neural correlates of consciousness: from psychedelics to hypnosis and meditation","volume":"CNNI0","author":"Moujaes","year":"2023","journal-title":"BPS"},{"key":"10.1016\/j.neubiorev.2025.106239_bib121","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2017.54","article-title":"Acute effects of LSD on amygdala activity during processing of fearful stimuli in healthy subjects","volume":"7","author":"Mueller","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106239_bib122","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.nicl.2018.03.005","article-title":"Altered network hub connectivity after acute LSD administration","volume":"18","author":"M\u00fcller","year":"2018","journal-title":"NeuroImage Clin."},{"key":"10.1016\/j.neubiorev.2025.106239_bib123","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/acps.12818","article-title":"Increased thalamic resting-state connectivity as a core driver of LSD-induced hallucinations","volume":"136","author":"M\u00fcller","year":"2017","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.neubiorev.2025.106239_bib124","doi-asserted-by":"crossref","first-page":"15171","DOI":"10.1523\/JNEUROSCI.2063-13.2013","article-title":"Broadband cortical desynchronization underlies the human psychedelic state","volume":"33","author":"Muthukumaraswamy","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2025.106239_bib125","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1080\/17512433.2021.1933434","article-title":"Blinding and expectancy confounds in psychedelic randomized controlled trials","volume":"14","author":"Muthukumaraswamy","year":"2021","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.neubiorev.2025.106239_bib126","article-title":"Emergency department visits involving hallucinogen use and risk of schizophrenia spectrum disorder","author":"Myran","year":"2024","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106239_bib127","first-page":"1","article-title":"Psychedelics reopen the social reward learning critical period","author":"Nardou","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2025.106239_bib128","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1124\/pr.115.011478","article-title":"Psychedelics","volume":"68","author":"Nichols","year":"2016","journal-title":"Pharm. Rev."},{"key":"10.1016\/j.neubiorev.2025.106239_bib129","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2022.119716","article-title":"Psilocybin modulation of time-varying functional connectivity is associated with plasma psilocin and subjective effects","volume":"264","author":"Olsen","year":"2022","journal-title":"Neuroimage"},{"key":"10.1016\/j.neubiorev.2025.106239_bib130","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1021\/acsptsci.0c00192","article-title":"The subjective effects of psychedelics may not be necessary for their enduring therapeutic effects","volume":"4","author":"Olson","year":"2021","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.neubiorev.2025.106239_bib131","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1007\/s00213-020-05464-5","article-title":"Tripping on nothing: placebo psychedelics and contextual factors","volume":"237","author":"Olson","year":"2020","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neubiorev.2025.106239_bib132","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.106589","article-title":"TMS-EEG and resting-state EEG applied to altered states of consciousness: oscillations, complexity, and phenomenology","volume":"26","author":"Ort","year":"2023","journal-title":"iScience"},{"issue":"71","key":"10.1016\/j.neubiorev.2025.106239_bib133","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.neubiorev.2025.106239_bib134","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1038\/s41598-024-52967-8","article-title":"Psilocybin-induced changes in neural reactivity to alcohol and emotional cues in patients with alcohol use disorder: an fMRI pilot study","volume":"14","author":"Pagni","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neubiorev.2025.106239_bib135","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.neuroimage.2019.06.053","article-title":"Spectral signatures of serotonergic psychedelics and glutamatergic dissociatives","volume":"200","author":"Pallavicini","year":"2019","journal-title":"Neuroimage"},{"key":"10.1016\/j.neubiorev.2025.106239_bib136","doi-asserted-by":"crossref","first-page":"20140873","DOI":"10.1098\/rsif.2014.0873","article-title":"Homological scaffolds of brain functional networks","volume":"11","author":"Petri","year":"2014","journal-title":"J. R. Soc. Interface"},{"key":"10.1016\/j.neubiorev.2025.106239_bib137","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.euroneuro.2016.01.005","article-title":"Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A\/2A agonist ergotamine on psilocybin-induced psychedelic experience","volume":"26","author":"Pokorny","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neubiorev.2025.106239_bib138","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104706","article-title":"The emerging science of microdosing: a systematic review of research on low dose psychedelics (1955\u20132021) and recommendations for the field","volume":"139","author":"Polito","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neubiorev.2025.106239_bib139","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1192\/bjp.bp.105.015263","article-title":"Psychological effects of ketamine in healthy volunteers. Phenomenological study","volume":"189","author":"Pomarol-Clotet","year":"2006","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106239_bib140","first-page":"197","article-title":"Psilocybin induces time-dependent changes in global functional connectivity","volume":"88","author":"Preller","year":"2020","journal-title":"Biol. Psychiatry Mech. Mood Disord."},{"key":"10.1016\/j.neubiorev.2025.106239_bib141","doi-asserted-by":"crossref","first-page":"5119","DOI":"10.1073\/pnas.1524187113","article-title":"Effects of serotonin 2A\/1A receptor stimulation on social exclusion processing","volume":"113","author":"Preller","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neubiorev.2025.106239_bib142","series-title":"Current Topics in Behavioral Neurosciences","first-page":"221","article-title":"Phenomenology, structure, and dynamic of psychedelic states","author":"Preller","year":"2018"},{"key":"10.1016\/j.neubiorev.2025.106239_bib143","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1093\/cercor\/13.8.870","article-title":"In vivo modulation of the activity of pyramidal neurons in the rat medial prefrontal cortex by 5-HT2A receptors: relationship to thalamocortical afferents","volume":"13","author":"Puig","year":"2003","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neubiorev.2025.106239_bib144","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0097794","article-title":"P300 aberration in first-episode schizophrenia patients: a meta-analysis","volume":"9","author":"Qiu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neubiorev.2025.106239_bib145","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/brain.2011.0019","article-title":"The restless brain","volume":"1","author":"Raichle","year":"2011","journal-title":"Brain Connect."},{"key":"10.1016\/j.neubiorev.2025.106239_bib146","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1001\/jama.2023.14530","article-title":"Single-dose psilocybin treatment for major depressive disorder: a randomized clinical trial","volume":"330","author":"Raison","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.neubiorev.2025.106239_bib147","article-title":"Psilocybin-induced changes in cerebral blood flow are associated with acute and baseline inter-individual differences |","volume":"13","author":"Rieser","year":"2023","journal-title":"Sci. Rep. Sci. Rep."},{"key":"10.1016\/j.neubiorev.2025.106239_bib148","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.neuropharm.2017.12.041","article-title":"Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression","volume":"142","author":"Roseman","year":"2018","journal-title":"Neuropharmacol. Psychedelic.: New Doors Alter. Percept."},{"key":"10.1016\/j.neubiorev.2025.106239_bib149","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3389\/fnhum.2014.00204","article-title":"The effects of psilocybin and MDMA on between-network resting state functional connectivity in healthy volunteers","volume":"8","author":"Roseman","year":"2014","journal-title":"Front. Hum. Neurosci."},{"key":"10.1016\/j.neubiorev.2025.106239_bib150","doi-asserted-by":"crossref","DOI":"10.1176\/appi.ajp.20220835","article-title":"Antidepressant effects of psilocybin in the absence of psychedelic effects","author":"Rosenblat","year":"2023","journal-title":"AJP"},{"key":"10.1016\/j.neubiorev.2025.106239_bib151","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1177\/0269881116675512","article-title":"Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial","volume":"30","author":"Ross","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neubiorev.2025.106239_bib152","article-title":"Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial","volume":"56","author":"von Rotz","year":"2023","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.neubiorev.2025.106239_bib153","first-page":"407","article-title":"Pitch and duration mismatch negativity and premorbid intellect in the first hospitalized schizophrenia spectrum","volume":"43","author":"Salisbury","year":"2017","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neubiorev.2025.106239_bib154","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41467-021-27876-3","article-title":"Premature commitment to uncertain decisions during human NMDA receptor hypofunction","volume":"13","author":"Salvador","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neubiorev.2025.106239_bib155","doi-asserted-by":"crossref","first-page":"8439","DOI":"10.1073\/pnas.1503686112","article-title":"Top-down control of the phase of alpha-band oscillations as a mechanism for temporal prediction","volume":"112","author":"Samaha","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neubiorev.2025.106239_bib156","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1111\/ejn.14080","article-title":"A review of plasticity induced by auditory and visual tetanic stimulation in humans","volume":"48","author":"Sanders","year":"2018","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neubiorev.2025.106239_bib157","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.neubiorev.2016.10.026","article-title":"Classical hallucinogens and neuroimaging: a systematic review of human studies: Hallucinogens and neuroimaging","volume":"71","author":"dos Santos","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neubiorev.2025.106239_bib158","doi-asserted-by":"crossref","DOI":"10.1038\/srep46421","article-title":"Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin","volume":"7","author":"Schartner","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neubiorev.2025.106239_bib159","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0137202","article-title":"Acute biphasic effects of ayahuasca","volume":"10","author":"Schenberg","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.neubiorev.2025.106239_bib160","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00213-012-2811-0","article-title":"The NMDA antagonist ketamine and the 5-HT agonist psilocybin produce dissociable effects on structural encoding of emotional face expressions","volume":"225","author":"Schmidt","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neubiorev.2025.106239_bib161","article-title":"Changes in music-evoked emotion and ventral striatal functional connectivity after psilocybin therapy for depression","author":"Shukuroglou","year":"2022","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neubiorev.2025.106239_bib162","first-page":"1","article-title":"Psilocybin desynchronizes the human brain","author":"Siegel","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2025.106239_bib163","doi-asserted-by":"crossref","DOI":"10.1007\/s00213-023-06478-5","article-title":"Psychedelic use and psychiatric risks","author":"Simonsson","year":"2023","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neubiorev.2025.106239_bib164","doi-asserted-by":"crossref","first-page":"7211","DOI":"10.1038\/s41598-024-55726-x","article-title":"Psilocybin enhances insightfulness in meditation: a perspective on the global topology of brain imaging during meditation","volume":"14","author":"Singer","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neubiorev.2025.106239_bib165","doi-asserted-by":"crossref","first-page":"5812","DOI":"10.1038\/s41467-022-33578-1","article-title":"Receptor-informed network control theory links LSD and psilocybin to a flattening of the brain\u2019s control energy landscape","volume":"13","author":"Singleton","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neubiorev.2025.106239_bib166","doi-asserted-by":"crossref","DOI":"10.1177\/02698811231179800","article-title":"Sub-acute effects of psilocybin on EEG correlates of neural plasticity in major depression: relationship to symptoms","author":"Skosnik","year":"2023","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neubiorev.2025.106239_bib167","doi-asserted-by":"crossref","unstructured":"Sloshower, J., Guss, J., Krause, R., 2020. The Yale Manual for Psilocybin-Assisted Therapy of Depression (using Acceptance and Commitment Therapy as a Therapeutic Frame). https:\/\/doi.org\/10.31234\/osf.io\/u6v9y.","DOI":"10.1016\/j.jcbs.2019.11.002"},{"key":"10.1016\/j.neubiorev.2025.106239_bib168","doi-asserted-by":"crossref","first-page":"4982","DOI":"10.1002\/hbm.25174","article-title":"P300-mediated modulations in self\u2013other processing under psychedelic psilocybin are related to connectedness and changed meaning: a window into the self\u2013other overlap","volume":"41","author":"Smigielski","year":"2020","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.neubiorev.2025.106239_bib169","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.neuroimage.2019.04.009","article-title":"Psilocybin-assisted mindfulness training modulates self-consciousness and brain default mode network connectivity with lasting effects","volume":"196","author":"Smigielski","year":"2019","journal-title":"NeuroImage"},{"key":"10.1016\/j.neubiorev.2025.106239_bib170","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2024.105570","article-title":"Who are you after psychedelics? A systematic review and a meta-analysis of the magnitude of long-term effects of serotonergic psychedelics on cognition\/creativity, emotional processing and personality","volume":"158","author":"Solaja","year":"2024","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neubiorev.2025.106239_bib171","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2022.948729","article-title":"Lasting increases in trait mindfulness after psilocybin correlate positively with the mystical-type experience in healthy individuals","volume":"13","author":"S\u00f8ndergaard","year":"2022","journal-title":"Front. Psychol."},{"key":"10.1016\/j.neubiorev.2025.106239_bib172","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1017\/S1092852918001013","article-title":"Beyond the dopamine hypothesis of schizophrenia to three neural networks of psychosis: dopamine, serotonin, and glutamate","volume":"23","author":"Stahl","year":"2018","journal-title":"CNS Spectr."},{"key":"10.1016\/j.neubiorev.2025.106239_bib173","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1177\/0269881120959609","article-title":"Brain serotonin 2A receptor binding predicts subjective temporal and mystical effects of psilocybin in healthy humans","volume":"35","author":"Stenb\u00e6k","year":"2021","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neubiorev.2025.106239_bib174","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1124\/pharmrev.121.000508","article-title":"Neural mechanisms and psychology of psychedelic ego dissolution","volume":"74","author":"Stoliker","year":"2022","journal-title":"Pharm. Rev."},{"key":"10.1016\/j.neubiorev.2025.106239_bib175","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.biopsych.2024.01.002","article-title":"Neural mechanisms of resting-state networks and the amygdala underlying the cognitive and emotional effects of psilocybin","volume":"96","author":"Stoliker","year":"2024","journal-title":"Biol. Psychiatry Depress. Treat. Biol."},{"key":"10.1016\/j.neubiorev.2025.106239_bib176","first-page":"1","article-title":"Neural mechanisms of psychedelic visual imagery","author":"Stoliker","year":"2024","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106239_bib177","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1177\/0269881110382466","article-title":"Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies","volume":"25","author":"Studerus","year":"2011","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neubiorev.2025.106239_bib178","doi-asserted-by":"crossref","first-page":"5442","DOI":"10.1002\/hbm.22562","article-title":"Enhanced repertoire of brain dynamical states during the psychedelic experience","volume":"35","author":"Tagliazucchi","year":"2014","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.neubiorev.2025.106239_bib179","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1126\/science.aah6066","article-title":"Active cortical dendrites modulate perception","volume":"354","author":"Takahashi","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.neubiorev.2025.106239_bib180","doi-asserted-by":"crossref","DOI":"10.1016\/j.pscychresns.2023.111777","article-title":"Amygdala biomarkers of treatment response in major depressive disorder: an fMRI systematic review of SSRI antidepressants","volume":"338","author":"Tassone","year":"2024","journal-title":"Psychiatry Res.: Neuroimaging"},{"key":"10.1016\/j.neubiorev.2025.106239_bib181","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-01209-2","article-title":"Psychedelics alter metaphysical beliefs","volume":"11","author":"Timmermann","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neubiorev.2025.106239_bib182","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2218949120","article-title":"Human brain effects of DMT assessed via EEG-fMRI","volume":"120","author":"Timmermann","year":"2023","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neubiorev.2025.106239_bib183","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-51974-4","article-title":"Neural correlates of the DMT experience assessed with multivariate EEG","volume":"9","author":"Timmermann","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neubiorev.2025.106239_bib184","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1177\/13634615221082796","article-title":"Towards psychedelic apprenticeship: developing a gentle touch for the mediation and validation of psychedelic-induced insights and revelations","volume":"59","author":"Timmermann","year":"2022","journal-title":"Transcult. Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106239_bib185","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1162\/netn_a_00349","article-title":"The unique neural signature of your trip: Functional connectome fingerprints of subjective psilocybin experience","volume":"8","author":"Tolle","year":"2024","journal-title":"Netw. Neurosci."},{"key":"10.1016\/j.neubiorev.2025.106239_bib186","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0006-3223(01)01242-2","article-title":"Mismatch negativity predicts psychotic experiences induced by nmda receptor antagonist in healthy volunteers","volume":"51","author":"Umbricht","year":"2002","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106239_bib187","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1001\/archpsyc.57.12.1139","article-title":"Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia","volume":"57","author":"Umbricht","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106239_bib188","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/sj.npp.1300005","article-title":"Effects of the 5-HT2A agonist psilocybin on mismatch negativity generation and AX-continuous performance task: implications for the neuropharmacology of cognitive deficits in schizophrenia","volume":"28","author":"Umbricht","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2025.106239_bib189","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104793","article-title":"Pharmacological, neural, and psychological mechanisms underlying psychedelics: a critical review","volume":"140","author":"van Elk","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neubiorev.2025.106239_bib190","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2020.117049","article-title":"Serotonergic psychedelics LSD & psilocybin increase the fractal dimension of cortical brain activity in spatial and temporal domains","volume":"220","author":"Varley","year":"2020","journal-title":"NeuroImage"},{"key":"10.1016\/j.neubiorev.2025.106239_bib191","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.3390\/jpm12061004","article-title":"Psilocybin-mediated attenuation of gamma band auditory steady-state responses (assr) is driven by the intensity of cognitive and emotional domains of psychedelic experience","volume":"12","author":"Viktorin","year":"2022","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.neubiorev.2025.106239_bib192","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.812180","article-title":"How psychedelic-assisted treatment works in the Bayesian brain","volume":"13","author":"Villiger","year":"2022","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106239_bib193","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/mp.2015.73","article-title":"Confidence and psychosis: a neuro-computational account of contingency learning disruption by NMDA blockade","volume":"21","author":"Vinckier","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106239_bib194","doi-asserted-by":"crossref","first-page":"7388","DOI":"10.1038\/s41598-017-06854-0","article-title":"Shannon entropy of brain functional complex networks under the influence of the psychedelic Ayahuasca","volume":"7","author":"Viol","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neubiorev.2025.106239_bib195","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcae049","article-title":"Brain dynamics predictive of response to psilocybin for treatment-resistant depression","volume":"6","author":"Vohryzek","year":"2024","journal-title":"Brain Commun."},{"key":"10.1016\/j.neubiorev.2025.106239_bib196","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0893-133X(96)00246-1","article-title":"Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis","volume":"16","author":"Vollenweider","year":"1997","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2025.106239_bib197","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41583-020-0367-2","article-title":"Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders","volume":"21","author":"Vollenweider","year":"2020","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neubiorev.2025.106239_bib198","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1097\/00001756-199812010-00024","article-title":"Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action","volume":"9","author":"Vollenweider","year":"1998","journal-title":"Neuroreport"},{"key":"10.1016\/j.neubiorev.2025.106239_bib199","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0893-133X(98)00108-0","article-title":"5-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man\u2013a PET study with [11C]raclopride","volume":"20","author":"Vollenweider","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2025.106239_bib200","doi-asserted-by":"crossref","DOI":"10.1176\/appi.ajp.20230751","article-title":"Reduced brain responsiveness to emotional stimuli with escitalopram but not psilocybin therapy for depression","author":"Wall","year":"2025","journal-title":"AJP"},{"key":"10.1016\/j.neubiorev.2025.106239_bib201","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jad.2023.04.081","article-title":"Increased low-frequency brain responses to music after psilocybin therapy for depression","volume":"333","author":"Wall","year":"2023","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neubiorev.2025.106239_bib202","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jcbs.2019.12.004","article-title":"The use of the psychological flexibility model to support psychedelic assisted therapy","volume":"15","author":"Watts","year":"2020","journal-title":"J. Context. Behav. Sci."},{"key":"10.1016\/j.neubiorev.2025.106239_bib203","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1177\/02698811241249698","article-title":"Measuring psychotherapeutic processes in the context of psychedelic experiences: validation of the general change mechanisms questionnaire (GCMQ)","volume":"38","author":"Wolff","year":"2024","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neubiorev.2025.106239_bib204","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1021\/acsptsci.0c00194","article-title":"The subjective effects of psychedelics are necessary for their enduring therapeutic effects","volume":"4","author":"Yaden","year":"2021","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.neubiorev.2025.106239_bib205","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/ijnp\/pyab026","article-title":"Psychedelics and consciousness: distinctions, demarcations, and opportunities","volume":"24","author":"Yaden","year":"2021","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neubiorev.2025.106239_bib206","doi-asserted-by":"crossref","first-page":"7438","DOI":"10.1073\/pnas.1405289111","article-title":"Altered global brain signal in schizophrenia","volume":"111","author":"Yang","year":"2014","journal-title":"PNAS"},{"key":"10.1016\/j.neubiorev.2025.106239_bib207","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2024.115886","article-title":"Efficacy and safety of psychedelics for the treatment of mental disorders: a systematic review and meta-analysis","volume":"335","author":"Yao","year":"2024","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.neubiorev.2025.106239_bib208","doi-asserted-by":"crossref","first-page":"938","DOI":"10.3390\/jcm11040938","article-title":"Trajectory of antidepressant effects after single- or two-dose administration of psilocybin: a systematic review and multivariate meta-analysis","volume":"11","author":"Yu","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.neubiorev.2025.106239_bib209","first-page":"1","article-title":"Prefrontal contributions to the stability and variability of thought and conscious experience","author":"Zamani","year":"2021","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.neubiorev.2025.106239_bib210","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1038\/s41598-023-28111-3","article-title":"From relaxed beliefs under psychedelics (REBUS) to revised beliefs after psychedelics (REBAS)","volume":"15","author":"Zeifman","year":"2025","journal-title":"Sci. Rep."}],"container-title":["Neuroscience & Biobehavioral Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763425002398?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763425002398?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T10:32:39Z","timestamp":1749637959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149763425002398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":210,"alternative-id":["S0149763425002398"],"URL":"https:\/\/doi.org\/10.1016\/j.neubiorev.2025.106239","relation":{},"ISSN":["0149-7634"],"issn-type":[{"value":"0149-7634","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurocognitive effects of psilocybin: A systematic and comprehensive review of neuroimaging studies in humans","name":"articletitle","label":"Article Title"},{"value":"Neuroscience & Biobehavioral Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neubiorev.2025.106239","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106239"}}